SUPRATHEL 250 as a Treatment for Oropharyngeal Wounds
NCT: NCT06543823 · RECRUITING
NCT IDNCT06543823
StatusRECRUITING
Start Date2025-04-30
Completion2027-04
SponsorAlaa Emara (OTHER)
First posted
Last updated
Brief Summary
To assess the use of Suprathel 250 for mucosal reconstruction in oropharyngeal defects. The membrane will be applied after tonsillectomy procedures and compared to bare wounds' healing
Frequently Asked Questions
What is SUPRATHEL 250 as a Treatment for Oropharyngeal Wounds?
SUPRATHEL 250 as a Treatment for Oropharyngeal Wounds is a clinical trial registered under NCT06543823. Current status: RECRUITING.
What is the status of NCT06543823?
The current status of NCT06543823 (SUPRATHEL 250 as a Treatment for Oropharyngeal Wounds) is: RECRUITING.
When did SUPRATHEL 250 as a Treatment for Oropharyngeal Wounds start?
SUPRATHEL 250 as a Treatment for Oropharyngeal Wounds started on 2025-04-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.